Viewing Study NCT03167957


Ignite Creation Date: 2025-12-24 @ 6:51 PM
Ignite Modification Date: 2026-02-20 @ 8:08 PM
Study NCT ID: NCT03167957
Status: WITHDRAWN
Last Update Posted: 2019-03-08
First Post: 2017-05-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Oral Encochleated Amphotericin B (CAMB) in the Treatment of Fluconazole-Resistant Vulvovaginal Candidiasis
Sponsor: Matinas BioPharma Nanotechnologies, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: MB-70008
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators